Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
about
Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLCPrognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.Quantification of heterogeneity as a biomarker in tumor imaging: a systematic reviewDoes early posttreatment surveillance imaging affect subsequent management following stereotactic body radiation therapy for early-stage non-small cell lung cancer?The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changesNew techniques for assessing response after hypofractionated radiotherapy for lung cancerThe role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning.Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?Cone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response.The Value of CBCT-based Tumor Density and Volume Variations in Prediction of Early Response to Chemoradiation Therapy in Advanced NSCLC.Quantitative texture analysis on pre-treatment computed tomography predicts local recurrence in stage I non-small cell lung cancer following stereotactic radiation therapy.Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer.Quantification of radiation-induced lung damage with CT scans: the possible benefit for radiogenomics.
P2860
Q28083924-C791FDC7-0213-4252-8A98-6C00DAF4598FQ29248453-80893290-5971-424A-AB90-344DDAF32E44Q35146660-2464DE49-3301-4F05-8878-2C25CD956031Q35350679-C61119E3-4A89-4373-9DAB-0D02399519B6Q36100808-97E153C3-F03F-4D9F-B338-C528F1FC6408Q36642258-BFADC80E-4884-4B88-9E2C-94CDC7FD1CF2Q37670432-588F7C41-47D5-4087-BAAD-EF30AF202F40Q38232757-89148073-AFF6-4826-ACB4-5C312F71BA65Q38849150-81A81764-3A6F-44BC-9D2D-C1517F774DE9Q42116312-27B010CB-EDA6-41DF-A926-E6FC6AA1A3FFQ47126042-267FEAD2-B5D0-4B6A-8F5C-ACB6D66CD668Q47191934-3ED5C9AC-FE20-4632-88DB-DCA0EF192BBAQ53076710-BB8278B8-8B5E-4FD8-9419-08622F5A9881Q53098022-804A727C-705C-4C48-9B6C-FCB56C6F7CFA
P2860
Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Distinguishing radiation fibro ...... nalysis of CT density changes.
@en
Distinguishing radiation fibro ...... eotactic ablative radiotherapy
@nl
type
label
Distinguishing radiation fibro ...... nalysis of CT density changes.
@en
Distinguishing radiation fibro ...... eotactic ablative radiotherapy
@nl
prefLabel
Distinguishing radiation fibro ...... nalysis of CT density changes.
@en
Distinguishing radiation fibro ...... eotactic ablative radiotherapy
@nl
P2093
P2860
P1433
P1476
Distinguishing radiation fibro ...... nalysis of CT density changes.
@en
P2093
Aaron D Ward
Cornelis J A Haasbeek
David A Palma
Sarah A Mattonen
P2860
P304
P356
10.3109/0284186X.2012.731525
P50
P577
2012-10-29T00:00:00Z